New support group aims to boost HIV med adherence for LGBTQ+ youth in brazil
NCT ID NCT06056037
First seen Nov 01, 2025
Summary
This study is testing a group support program to help young sexual and gender minority people (ages 18-24) in Rio de Janeiro, Brazil, take their HIV medication regularly. The program includes four group sessions that focus on building social support, self-confidence, and problem-solving skills. Researchers will measure how well the program works by checking medication levels in urine and pharmacy records.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Evandro Chagas National Institute of Infectious Diseases (INI) Oswaldo Cruz Foundation (FIOCRUZ)
RECRUITINGRio de Janeiro, Brazil
Contact
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
behavioral intervention (group support sessions)
What this could lead to
If successful, this could provide a low-cost, scalable way to help young people with HIV stay on their medication and achieve better health outcomes.
What could go wrong
This is a small pilot study with only 72 participants, so results may not apply broadly. The intervention is behavioral, so its impact on adherence may be limited without addressing other barriers.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.